Monte Rosa Therapeutics, Inc.GLUENASDAQ
Loading
Gross Profit Over TimeExpanding
Percentile Rank100
Studio
Year-over-Year Change

Revenue minus cost of goods sold

Latest
$119.49M
↑ 364% vs avg
Percentile
P100
Near historical high
Streak
2 yr
Consecutive growthExpanding
Average
$25.74M
Historical baseline
PeriodValueYoY Change
TTM$119.49M+77.0%
2024$67.50M+1184.9%
2023$-6.22M-
2022$0.00-
2021$0.00+100.0%
2020$-537000.00-645.8%
2019$-72000.00-